WallStreetZenWallStreetZen

NYSE: TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD Earnings & Revenue

TEVA past revenue growth

How has TEVA's revenue growth performed historically?
Company
-4.45%
Industry
128.36%
Market
49.94%
TEVA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TEVA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

TEVA earnings and revenue history

Current Revenue
$15.6B
Current Earnings
-$615.0M
Current Profit Margin
-4%

TEVA Return on Equity

Current Company
-6.1%
Current Industry
17.6%
Current Market
38.4%
TEVA's Return on Equity (-6.1%)... subscribe to Premium to read more.
High Return on Equity Performance

TEVA Return on Assets

Current Company
-1.3%
Current Industry
5.2%
TEVA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TEVA Return on Capital Employed

Current Company
1.59%
Current Industry
10%
TEVA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TEVA vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TEVA$15.56B$1.84B-$615.00M-7.52%N/A
RDY$2.55B$540.77M$232.01M+2.06%-4.36%
ELAN$4.75B$501.00M-$363.00M+81.97%N/A
PRGO$4.20B$674.40M-$109.40M-3.90%N/A
VTRS$17.65B$4.74B$167.70M+8.74%-33.04%

TEVA PHARMACEUTICAL INDUSTRIES Earnings & Revenue FAQ

What were TEVA's earnings last quarter?

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) reported Q1 2022 earnings per share (EPS) of -$0.86, up 1,328.57% year over year. Total TEVA PHARMACEUTICAL INDUSTRIES earnings for the quarter were -$955.00 million. In the same quarter last year, TEVA PHARMACEUTICAL INDUSTRIES's earnings per share (EPS) was $0.07.

What was TEVA's earnings growth in the past year?

As of Q2 2022, TEVA PHARMACEUTICAL INDUSTRIES's earnings has grown null year over year. TEVA PHARMACEUTICAL INDUSTRIES's earnings in the past year totalled -$615.00 million.

What was TEVA's revenue last quarter?

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) reported Q1 2022 revenue of $3.66 billion up 8.06% year over year. In the same quarter last year, TEVA PHARMACEUTICAL INDUSTRIES's revenue was $3.98 billion.

What was TEVA's revenue growth in the past year?

As of Q2 2022, TEVA PHARMACEUTICAL INDUSTRIES's revenue has grown -4.45% year over year. This is 132.81 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 128.36%. TEVA PHARMACEUTICAL INDUSTRIES's revenue in the past year totalled $15.56 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.